Rothschild & Co Redburn Issues Pessimistic Forecast for CME Group (NASDAQ:CME) Stock Price
by Teresa Graham · The Cerbat GemCME Group (NASDAQ:CME – Get Free Report) had its price objective reduced by equities researchers at Rothschild & Co Redburn from $340.00 to $316.00 in a report issued on Monday,MarketScreener reports. The firm presently has a “neutral” rating on the financial services provider’s stock. Rothschild & Co Redburn’s price target would indicate a potential upside of 10.92% from the stock’s previous close.
A number of other analysts also recently weighed in on the company. Argus restated a “hold” rating on shares of CME Group in a report on Wednesday, March 4th. Wall Street Zen downgraded CME Group from a “hold” rating to a “sell” rating in a report on Sunday. Jefferies Financial Group decreased their price objective on CME Group from $356.00 to $349.00 and set a “buy” rating for the company in a report on Thursday, April 9th. Weiss Ratings upgraded CME Group from a “buy (b+)” rating to a “buy (a-)” rating in a report on Monday, March 2nd. Finally, Raymond James Financial increased their price target on CME Group from $310.00 to $320.00 and gave the stock an “outperform” rating in a report on Monday, April 6th. Two equities research analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating, six have given a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat.com, CME Group presently has an average rating of “Moderate Buy” and a consensus price target of $305.29.
Read Our Latest Analysis on CME
CME Group Trading Down 0.1%
NASDAQ CME traded down $0.16 on Monday, reaching $284.90. The company had a trading volume of 259,478 shares, compared to its average volume of 2,291,647. The firm has a market cap of $102.17 billion, a price-to-earnings ratio of 24.26, a P/E/G ratio of 3.45 and a beta of 0.26. CME Group has a fifty-two week low of $257.17 and a fifty-two week high of $329.16. The business has a 50 day moving average of $304.51 and a two-hundred day moving average of $286.38. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.03.
CME Group (NASDAQ:CME – Get Free Report) last posted its quarterly earnings data on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share for the quarter, beating analysts’ consensus estimates of $3.11 by $0.25. The business had revenue of $1.88 billion during the quarter, compared to the consensus estimate of $1.77 billion. CME Group had a return on equity of 15.42% and a net margin of 63.19%.CME Group’s quarterly revenue was up 14.5% on a year-over-year basis. During the same period in the prior year, the business posted $2.80 earnings per share. Analysts forecast that CME Group will post 12.24 EPS for the current year.
Insider Activity at CME Group
In related news, General Counsel Jonathan L. Marcus sold 3,291 shares of the business’s stock in a transaction on Tuesday, March 17th. The shares were sold at an average price of $333.37, for a total transaction of $1,097,120.67. Following the transaction, the general counsel owned 7,192 shares in the company, valued at $2,397,597.04. The trade was a 31.39% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Bryan T. Durkin sold 4,200 shares of the business’s stock in a transaction on Monday, February 23rd. The shares were sold at an average price of $309.65, for a total transaction of $1,300,530.00. Following the transaction, the director owned 43,007 shares in the company, valued at $13,317,117.55. The trade was a 8.90% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 8,539 shares of company stock worth $2,713,821 over the last quarter. 0.30% of the stock is currently owned by insiders.
Institutional Trading of CME Group
Several large investors have recently made changes to their positions in the company. Truist Financial Corp grew its position in CME Group by 8.9% during the 3rd quarter. Truist Financial Corp now owns 70,712 shares of the financial services provider’s stock worth $19,106,000 after acquiring an additional 5,773 shares during the last quarter. Alley Investment Management Company LLC lifted its position in CME Group by 86.0% in the third quarter. Alley Investment Management Company LLC now owns 29,223 shares of the financial services provider’s stock valued at $7,896,000 after purchasing an additional 13,512 shares during the last quarter. Elevate Capital Advisors LLC boosted its stake in shares of CME Group by 85.2% during the third quarter. Elevate Capital Advisors LLC now owns 8,519 shares of the financial services provider’s stock valued at $2,302,000 after purchasing an additional 3,919 shares during the period. SG Americas Securities LLC grew its holdings in shares of CME Group by 345.2% in the fourth quarter. SG Americas Securities LLC now owns 237,898 shares of the financial services provider’s stock worth $64,965,000 after purchasing an additional 184,459 shares during the last quarter. Finally, Ashton Thomas Private Wealth LLC grew its holdings in shares of CME Group by 78.8% in the third quarter. Ashton Thomas Private Wealth LLC now owns 13,281 shares of the financial services provider’s stock worth $3,588,000 after purchasing an additional 5,855 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors and hedge funds.
CME Group Company Profile
CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.
The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.